Scientific Advisory Board

BCAN’s Scientific Advisory Board (SAB) is composed of distinguished leading academic urologists, oncologists, radiation oncologists, and pathologists working within the bladder cancer field, representing many of the major cancer centers in the U.S and Canada. All have made outstanding contributions in their own fields and we are proud to have their involvement on our behalf.
  • Elizabeth Plimack – SAB Chairperson

    Fox Chase Cancer Center- Philadelphia, PA

    Fox Chase Cancer Center- Philadelphia, PA Read More
  • Hikmat Al-Ahmadie, MD

    Memorial Sloan-Kettering Cancer Center – New York, NY

    Memorial Sloan-Kettering Cancer Center – New York, NY Read More
  • Andrea Apolo, MD

    National Cancer Institute – Bethesda, MD

    National Cancer Institute – Bethesda, MD Read More
  • Jeanny B. Aragon-Ching, MD, FACP

    Inova Schar Cancer Institute – Fairfax, VA

    Inova Schar Cancer Institute - Fairfax, VA Read More
  • Trinity J. Bivalacqua, MD, PhD

    University of Pennsylvania - Philadelphia, PA

    Johns Hopkins Medical Institutions – Baltimore, MD Read More
  • Sam Chang, MD

    Vanderbilt University School of Medicine – Nashville, TN

    Vanderbilt University School of Medicine – Nashville, TN Read More
  • Peter Clark, MD

    Vanderbilt University School of Medicine – Nashville, TN

    Vanderbilt University School of Medicine – Nashville, TN Read More
  • Sia Daneshmand, MD

    USC/Norris Comprehensive Cancer Center – Los Angeles, CA

    USC/Norris Comprehensive Cancer Center – Los Angeles, CA Read More
  • Rian J. Dickstein, MD

    Chesapeake Urology – Glen Burnie, MD

    Chesapeake Urology – Glen Burnie, MD Read More